Company Overview of KaloBios Pharmaceuticals, Inc.
Key Executives for KaloBios Pharmaceuticals, Inc.
|Cameron Durrant M.D., MBA||58 Relationships||Chairman, Chief Executive Officer, Chairman of Audit Committee, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee||55|
|Dean Witter III||No Relationships||Interim Chief Financial Officer||68|
|Morgan Lam||No Relationships||Chief Operating Officer||51|
|Charles J. Democko||No Relationships||Senior Vice President of Regulatory Affairs and Quality||61|
KaloBios Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Cameron Durrant M.D., MBA||58 Relationships||KaloBios Pharmaceuticals, Inc.||55|
|James W. Larrick M.D., Ph.D.||39 Relationships||KaloBios Pharmaceuticals, Inc.||--|
|Ronald Barliant||5 Relationships||KaloBios Pharmaceuticals, Inc.||--|
|Dale Chappell||5 Relationships||Black Horse Capital Advisors LLC||--|
|Timothy Morris||5 Relationships||KaloBios Pharmaceuticals, Inc.||--|
KaloBios Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee M.D., MBA||Cameron Durrant||58 Relationships||2 Executives|
|Compensation Committee M.D., MBA||Cameron Durrant||58 Relationships||2 Executives|
|Nominating Committee||Ronald Barliant||5 Relationships||2 Executives|
|Corporate Governance Committee||Ronald Barliant||5 Relationships||2 Executives|
|Advisory Board M.D., Ph.D.||James W. Larrick||39 Relationships||1 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.